The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Feb 2015 07:00

RNS Number : 8398D
Immunodiagnostic Systems Hldgs PLC
03 February 2015
 



 

 

RNS Announcement

3 February 2015

 

Immunodiagnostic Systems Holdings plc

Patricio Lacalle Appointed New Chief Executive Officer

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets quoted on AIM, today announces that Patricio Lacalle has been appointed Chief Executive Officer and will join IDS as a Director effective 1 April 2015.

Patricio is currently the CEO of Pulsion Medical Systems SE, a medical technology company with a leading market position in hemodynamic monitoring. In the four years which he has spent at Pulsion Patricio and his team were able to lead the company to international growth while significantly expanding the operating margin. Before Pulsion Patricio held a number of management positions at Forbo Adhesives and HB Fuller.

On 1 April 2015, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman.

Dr Burkhard Wittek, Executive Chairman of Immunodiagnostic Systems, said "IDS is delighted to announce the appointment of Patricio as Chief Executive Officer. We have worked together at Pulsion and were able to build a company setting standards of business quality in its field. Patricio brings to IDS a strong business sense, a bias for action and great team building and leadership skills. Our leadership team at IDS is looking forward to working with Patricio and together achieving our ambitions for driving growth and profitability."

The following disclosures are made in accordance with AIM rule 17 and Schedule 2 paragraph (g) of the AIM Rules:

Carlos Patricio Lacalle Zando, aged 49 is currently a director of Pulsion Medical Systems SE, Germany, Pulsion Medical UK Ltd., Pulsion France S.A.R.L., Pulsion Austria GmbH, Pulsion Medical Inc., USA, Pulsion Benelux N.V., Belgium, Pulsion Pacific PTY., Australia, Pulsion Switzerland GmbH, Pulsion Poland Sp.z.o.o., Pulsion Iberica S.L, Spain, Pulsion Medical Systems S. de RL de CV, Mexico, Pulsion Medical Systems Medikal Ürünler Ticaret Limited Sirketi, Turkey and in the previous five years he has also been a director of Forbo Adhesives Deutschland GmbH and Forbo Adhesives Schweiz AG.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQAPUPAPUP
Date   Source Headline
10th Sep 20147:00 amRNSAcquisition of Dia.Metra S.r.l.
21st Aug 20147:00 amRNSChinese FDA clearance for the IDS-iSYS instrument
4th Aug 20145:59 pmRNSAGM Results
4th Aug 20147:00 amRNSAGM Statement
30th Jul 201410:25 amRNSAdditional Listing
14th Jul 201411:36 amRNS2014 Annual Report & Accounts and Notice of AGM
24th Jun 20147:00 amRNSFinal Results
12th May 201410:51 amRNSHolding(s) in Company
15th Apr 20147:00 amRNSTrading Statement
13th Mar 20144:40 pmRNSSecond Price Monitoring Extn
13th Mar 20144:35 pmRNSPrice Monitoring Extension
7th Mar 20147:00 amRNSDirectorate Change
15th Jan 20144:28 pmRNSHolding(s) in Company
9th Jan 20147:00 amRNSFDA clearance of Direct Renin assay on IDS-iSYS
8th Jan 201412:47 pmRNSAdditional Listing
19th Dec 20134:36 pmRNSAdditional Listing
12th Dec 20136:20 pmRNSHolding(s) in Company
12th Dec 20136:19 pmRNSHolding(s) in Company
27th Nov 20137:00 amRNSHalf Yearly Report
10th Oct 20137:00 amRNSTrading Statement
8th Oct 20134:29 pmRNSHolding(s) in Company
8th Oct 20134:26 pmRNSHolding(s) in Company
27th Sep 201312:40 pmRNSHolding(s) in Company
24th Sep 20131:15 pmRNSAdditional Listing
4th Sep 20137:00 amRNSHolding(s) in Company
28th Aug 201312:46 pmRNSAdditional Listing
31st Jul 201312:20 pmRNSAdditional Listing
29th Jul 20133:24 pmRNSHolding(s) in Company
26th Jul 20133:08 pmRNSResult of AGM
26th Jul 201312:00 pmRNSAGM Statement
2nd Jul 20139:41 amRNSDirector/PDMR Shareholding
28th Jun 20139:46 amRNSAdditional Listing
28th Jun 20139:00 amRNSAnnual Report and AGM
26th Jun 20137:00 amRNSAdditional Listing
24th Jun 20137:00 amRNSFDA clearance of 1,25-Dihydroxy Vitamin D assay
21st Jun 20137:00 amRNSImmunodiagnostic Systems streamlines Board
17th Jun 20137:00 amRNSFinal Results
10th May 20134:29 pmRNSHolding(s) in Company
9th May 20133:22 pmRNSAdditional Listing
2nd May 20137:41 amRNSEntry into Chinese Diagnostics Market
25th Apr 20134:17 pmRNSTrading Update - Replacement
23rd Apr 20139:45 amRNSHolding(s) in Company
16th Apr 20135:03 pmRNSHolding(s) in Company
16th Apr 201311:42 amRNSHolding(s) in Company
10th Apr 20137:00 amRNSDistribution Agreement
10th Apr 20137:00 amRNSTrading Statement
5th Apr 201310:22 amRNSDirector/PDMR Shareholding
4th Apr 20134:43 pmRNSHolding(s) in Company
11th Feb 20137:00 amRNSCollaboration with Diagnostica Stago
14th Dec 20122:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.